Patient cohort description and demographics
| Variable . | Value . |
|---|---|
| Total patients | 58 |
| Age, range (median) | 35-86 (67.5) |
| Sex | |
| Male | 44 |
| Female | 14 |
| Race | |
| White | 34 |
| Black or African American | 4 |
| Asian | 3 |
| Other | 15 |
| ISS | |
| I | 22 |
| II | 10 |
| III | 16 |
| N/A | 10 |
| Therapy lines | |
| Median | 4 |
| Min | 1 |
| Max | 18 |
| Cytogenetics | |
| t(11;14) | 48 |
| t(4;14) | 0 |
| t(6;14) | 0 |
| gain(1q) | 23 |
| t(11;14) and gain(1q) | 19 |
| BCL2 IHC | |
| 1 | 3 |
| 2 | 4 |
| 3 | 26 |
| N/A | 17 |
| Variable . | Value . |
|---|---|
| Total patients | 58 |
| Age, range (median) | 35-86 (67.5) |
| Sex | |
| Male | 44 |
| Female | 14 |
| Race | |
| White | 34 |
| Black or African American | 4 |
| Asian | 3 |
| Other | 15 |
| ISS | |
| I | 22 |
| II | 10 |
| III | 16 |
| N/A | 10 |
| Therapy lines | |
| Median | 4 |
| Min | 1 |
| Max | 18 |
| Cytogenetics | |
| t(11;14) | 48 |
| t(4;14) | 0 |
| t(6;14) | 0 |
| gain(1q) | 23 |
| t(11;14) and gain(1q) | 19 |
| BCL2 IHC | |
| 1 | 3 |
| 2 | 4 |
| 3 | 26 |
| N/A | 17 |
IHC, immunohistochemistry; ISS, International Staging System; Max, Maximum; Min, Minimum; N/A, Not available.